Community News

published September 30, 2023
Challenging time: Guy Dunn and Eva Driver are sp
published May 23, 2023
Thank you Lymphoma LEGends!!! During March and April more than 600 pairs of legs hit the pavement, lapped the

Newsletters

published May 8, 2025
December 2024 Inside this edition, we will be covering keeping safe over chr Upcoming events Lymphoma A
published May 8, 2025
Novemb 2024 Inside this edition, we will be covering lung changes and lymphoma, clincial trials, new tre

Media

published July 12, 2024
Gilead welcomes the opening of Australia’s first regional CAR T-cell treatment centre at Townsville Hospital
published April 12, 2023
Media Release: Blood cancer group’s five decades of research for better treatments

Research

Share This

Contact Lymphoma Australia Today!

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.